{
    "nct_id": "NCT04495478",
    "official_title": "A Single-Dose Study in Healthy Participants to Characterize Ramucirumab Pharmacokinetics and Investigate Injection Site Reactions Following an Intravenous Infusion or Subcutaneous Administration of Ramucirumab",
    "inclusion_criteria": "* Overtly healthy male or a female (not pregnant and agreeable to take birth control measures until study completion)\n* Have a body weight greater than or equal to (≥)70 kilograms (kg) and body mass index (BMI) of 18 to 32 kilogram per square meter (kg/m ²), inclusive\n* Have normal blood pressure, pulse rate, electrocardiogram (ECG), and blood and urine laboratory test results that are acceptable for the study\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 60 Years",
    "exclusion_criteria": "* Are currently participating in or completed a clinical trial within the last 30 days or any other type of medical research judged to be incompatible with this study\n* Have previously participated or withdrawn from this study\n* Have or used to have health problems or laboratory test results or ECG readings that, in the opinion of the doctor, could make it unsafe to participate, or could interfere with understanding the results of the study\n* Had blood loss of more than 500 milliliters (mL) within the previous 30 days of study screening",
    "miscellaneous_criteria": ""
}